Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-06-27 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 Annual General Meeting (AGM) of Shenzhen Huitai Medical Devices Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals including the 2023 annual report, financial statements, profit distribution, appointment of auditors, and remuneration plans. The document is not the annual report itself but the official announcement of the AGM resolutions and voting outcomes. The length is under 5,000 characters and it focuses on the meeting and voting results rather than presenting financial data or management discussion. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-27 Chinese
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2023年年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, and voting results of the 2023 Annual General Meeting (AGM) of Shenzhen Huitai Medical Devices Co., Ltd. It details the legal compliance of the AGM process, including the notice, voting methods, and resolutions passed. The document does not contain the actual annual report or financial statements but focuses on the AGM procedural legality and voting outcomes. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including legal opinions on the meeting itself. The document length is 3503 characters, which is consistent with a detailed AGM-related legal opinion rather than a full annual report or other filings.
2024-06-27 Chinese
2023年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "2023 年年度股东大会会议资料" which translates to "2023 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda items, meeting instructions, and proposals to be discussed and voted on at the AGM, including the 2023 Annual Report, Board Work Report, Financial Statements, Profit Distribution Plan, Auditor Appointment, and other governance and operational matters. The content is clearly the materials prepared for the shareholders to review and discuss during the AGM, not the actual annual report or financial statements themselves. The document length is about 15,000 characters, which is consistent with detailed AGM materials. Therefore, this document fits the category of AGM Information (AGM-R).
2024-06-19 Chinese
2024年第二次独立董事专门会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the independent directors' special meeting of Shenzhen Huitai Medical Device Co., Ltd. It discusses approval of matters related to the company's 2021 restricted stock incentive plan, including cancellation of some unvested restricted stocks and confirmation of vesting conditions for certain classes of restricted stocks. The document includes voting results and signatures of the independent directors. It is a formal board/management meeting resolution related to stock incentive plans, not a full annual report, earnings release, or other financial report. It is not a proxy solicitation or voting results announcement but a management/board decision document. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board resolutions, confirming this classification.
2024-06-13 Chinese
第二届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Shenzhen Huitai Medical Devices Co., Ltd. It details the approval of proposals related to the company's 2021 restricted stock incentive plan, including the cancellation of some unvested restricted stocks and confirmation of vesting conditions for certain stock grants. The document includes voting results and references related announcements on the Shanghai Stock Exchange website. It is not a full report like an annual or interim report, nor is it a financial statement or earnings release. It is not a proxy solicitation or AGM material, but rather a board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters. The document length is short and focused on board resolutions, confirming the classification as MANG rather than a full report or regulatory filing.
2024-06-13 Chinese
关于作废2021年限制性股票激励计划部分已授予但尚未归属的限制性股票的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the cancellation of certain restricted stocks granted but not yet vested under the 2021 restricted stock incentive plan. It details board and supervisory meetings, approvals, legal opinions, and the impact of the cancellation on the company and shareholders. The content focuses on corporate governance and management decisions related to stock incentives rather than financial results or audit information. It is not a full annual or interim report, nor an earnings release or capital update. It is a formal announcement about management decisions on stock incentives, which fits best under Board/Management Information (MANG). The document length is 4425 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the classification is MANG with high confidence.
2024-06-13 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.